Insider Trading & Ownership of Magda Marquet

Location
San Diego, WA
Summary
The estimated net worth of Magda Marquet is at least $1,608,030 dollars as of 14 May 2026. Magda Marquet is the Director of Arcturus Therapeutics Holdings Inc. and owns shares of Arcturus Therapeutics Holdings Inc. (ARCT) stock worth about $899.2K. Magda Marquet is the Director of ANAPTYSBIO, INC and owns shares of ANAPTYSBIO, INC (ANAB) stock worth about $577.3K. Magda Marquet is the Director of Immix Biopharma, Inc. and owns shares of Immix Biopharma, Inc. (IMMX) stock worth about $131.5K.
Signature
/s/ Ajim Tamboli, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Magda Marquet and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Key facts

  • Magda Marquet has 5 issuer positions tracked on this page.
  • Estimated disclosed ownership value: $1,608,030.
  • Recent insider filing activity is available below.

Change

  • Largest disclosed position: Arcturus Therapeutics Holdings Inc. ($899,178).
  • Past-year value change for that position: .

Research use

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Magda Marquet

ANAB Forms 3/4/5

ANAPTYSBIO, INC

Relationship
Director
Holdings value
$577,329
Past year net change
-$530,531
Change %
-48%
Report period
15 Jan 2026

Insider Transactions Reported by Magda Marquet:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .